These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6809683)

  • 1. Long-term study of fluvoxamine: a new rapid-acting antidepressant.
    Feldmann HS; Denber HC
    Int Pharmacopsychiatry; 1982; 17(2):114-22. PubMed ID: 6809683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Belgian multicentre study of fluvoxamine in depressive outpatients.
    Brasseur R; Van Moffaert M; Mesotten F; Ansseau M; Uytdenhoef P; Bartholome F
    Acta Psychiatr Belg; 1985; 85(5):636-43. PubMed ID: 3937441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine and imipramine: results of a long-term controlled trial.
    Guelfi JD; Dreyfus JF; Pichot P
    Int Clin Psychopharmacol; 1987 Apr; 2(2):103-9. PubMed ID: 3110264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice.
    Hamilton BA; Jones PG; Hoda AN; Keane PM; Majid I; Zaidi SI
    Pharmatherapeutica; 1989; 5(5):292-7. PubMed ID: 2501801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.
    Dick P; Ferrero E
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):419S-425S. PubMed ID: 6407502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine and chlorimipramine in endogenous depression.
    De Wilde JE; Doogan DP
    J Affect Disord; 1982 Sep; 4(3):249-59. PubMed ID: 6215443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.
    Roth D; Mattes J; Sheehan KH; Sheehan DV
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):929-39. PubMed ID: 2126144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people.
    Phanjoo AL; Wonnacott S; Hodgson A
    Acta Psychiatr Scand; 1991 Jun; 83(6):476-9. PubMed ID: 1909083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
    Wakelin JS
    Int Clin Psychopharmacol; 1986 Jul; 1(3):221-30. PubMed ID: 3104446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affective disorders in general practice. Treatment of 6000 patients with fluvoxamine.
    Martin AJ; Tebbs VM; Ashford JJ
    Pharmatherapeutica; 1987; 5(1):40-9. PubMed ID: 3110794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing.
    De Wilde JE; Mertens C; Wakelin JS
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):427S-431S. PubMed ID: 6407503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study.
    Gonella G; Baignoli G; Ecari U
    Curr Med Res Opin; 1990; 12(3):177-84. PubMed ID: 2125547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
    Norton KR; Sireling LI; Bhat AV; Rao B; Paykel ES
    J Affect Disord; 1984 Dec; 7(3-4):297-308. PubMed ID: 6241211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.